Background/Aims: The aim of this study was to investigate the involvement of inducible co-stimulatory ligand (ICOSL) expression in stimulation of mast cells (MCs) by TNF-α and the ability of TNF-α stimulation of MCs to influence CD4+ T cell differentiation and function. The mechanisms underlying TNF-α stimulation of MCs were also explored. Methods: Mast cells and CD4 + T cells were prepared from C57BL/6 mice (aged 6-8 weeks). ICOSL expression by MCs was measured by real-time PCR and flow cytometry, and levels of IL-4, IL-10 and IFN-γ were measured by ELISA. Results: ICOSL expression by MCs was increased by TNF-α stimulation, and resulted in interaction with CD4+ T cells. The IL-4 and IL-10 levels in the coculture system increased, while IFN-γ levels decreased. Furthermore, CD4+CD25+Foxp3+ T cell proliferation was induced by co-culture with TNF-α-stimulated MCs. The mechanism by which TNF-α stimulated MCs was dependent on the activation of the MAPK signaling pathway. Conclusion: TNF-α upregulated the expression of ICOSL on mast cells via a mechanism that is dependent on MAPK phosphorylation. TNF-α-treated MCs promoted the differentiation of regulatory T cells and induced a shift in cytokine expression from a Th1 to a Th2 profile by up-regulation ICOSL expression and inhibition of MC degranulation. Our study reveals a novel mechanism by which mast cells regulate T cell function.
Introduction
Mast cells (MCs) are widely distributed in the connective and vascularized tissues or cavities throughout the body and play an important role in the interaction between the immune system and environmental antigens and allergens [1, 2] . Following exposure to a variety of pathological conditions, the phenotypic profile of MCs is influenced by various micro-environmental stimuli [3] leading to different functional effects [4] [5] [6] . This versatility is reflected in the IgE-dependent and -independent activation pathways that modulate MC responses [7] . Thus, through interactions with immune cells, MCs mediate different regulatory impacts on the immune system through the release of a wide variety of preexisting and de novo-synthesized mediators [2, 6] .
In recent years, co-stimulatory signals in the immune system have shown promise for the targeted treatment of diseases [8] [9] [10] . Actually, the MC surface also expresses a broad array of molecules involved in cell-cell interactions that mediate the delivery of essential signals in response to multiple types of exogenous stimulation [11, 12] . However, the relationships between co-stimulatory molecules and MCs are still unclear. The influences of changes in the expression of co-stimulatory molecules by MCs and secreted products on various T cells functions and the underlying mechanisms remain to be clarified. According to previous studies, toll-like receptors (TLRs) activate MCs to recognize pathogen-associated molecular patterns, resulting in the secretion of cytokines that promote adaptive immune responses [13] [14] [15] . These findings provided convincing evidence for a pro-inflammatory role of MCs by focusing mainly on the acute phase response or the recurrence of autoimmune and inflammatory diseases [7, 16] . TNF-α is a common factor involved in different pathological conditions [11, 17] ; thus, elucidation of its impact on MCs in regulating immune responses is an important and challenging task.
In this study, we investigated MC expression of ICOSL, which is the third member of B7 superfamily [18] [19] [20] to clarify its relationship with TNF-α. Furthermore, we explored the impacts of changes in MC expression of ICOSL on T cells. To address this question, initially, we used TNF-α to stimulate MCs and analyzed the level of ICOSL expression. We hypothesized that changes in MC expression of ICOSL could influence MC membrane stabilization, which suggests a function in immune cell regulation.
Materials and Methods

Antibodies and reagents
Anti-DNP monoclonal IgE, DNP-HSA and p-nitrophenyl-N-acetyl-b-D-glucosaminide were purchased from Sigma-Aldrich (St. Louis, MO, USA). Mouse monoclonal anti-MC tryptase antibody was purchased from Abcam (Cambridge, UK). Antibodies against β-actin, p38, phospho-p38, ERK1/2, phospho-ERK1/2, and JNK, phospho-JNK were purchased from Cell Signaling Technology (Beverly, MA, USA). Dulbecco's modified Eagle's medium and fetal bovine serum (FBS) were purchased from GIBCO (Grandland, NY, USA). Recombinant murine IL-3, recombinant murine stem cell factor (SCF) and recombinant murine TNF-α were purchased from Pretech (Rocky Hill, NJ, USA).
Mice
Male C57BL/6 mice (aged 6-8 weeks) were purchased from Schleck Experimental Animals Co. (Shanghai, China). ICOSL −/− mice (C57BL/6) were purchased from Jackson Laboratory. All mice were housed in a specific pathogen-free facility and used in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals of the Chinese Academy of Sciences.
Cell preparation Murine bone marrow-derived mast cells (BMMCs).
Murine BMMCs were obtained as described previously [21] . Briefly, bone marrow cells were isolated from femurs of C57BL/6 mice, cultured in complete RPMI (Gibco, Grand Island, NY, USA), and supplemented with 10% FBS (Gibco, Grand Island, NY, USA), 100 U/ mL penicillin/streptomycin (Gibco, USA), 10 ng/mL recombinant murine IL-3 (Pretech, Rocky Hill, NJ), and 10 ng/mL recombinant murine SCF (Pretech, Rocky Hill, NJ) at 37ºC under 5% CO 2 . Seven days later, nonadherent cells were carefully removed and replaced with fresh culture medium to enhance the purity of the MCs; this step was repeated every 7 days until adherent cells disappeared (after 5-6 passages). The purity of BMMCs was assessed by flow cytometric analysis of the expression of c-kit (CD117) and FCεRIα. BMMCs were used at a purity exceeding 90%.
CD4+ T cells. CD4+ T cells were prepared from spleens using the CD4+CD25+ T Cell Isolation Kit (Miltenyi Biotech, Shanghai, China) according to the manufacturer's instructions. According to flow cytometric analysis, the final purity of CD4+ T cells exceeded 90%.
MTT assays
Cytotoxicity of different doses of TNF-α for 24h on MCs were assessed by colorimetric 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay as described in the previous report [22] .
Western blot analysis
Western blotting was conducted as described previously [23] . In brief, cell lysates were centrifuged at 12, 000 rpm for 30 min at 4°C. Protein concentrations of cell lysates were determined with the BCA assay (Pierce) and 40 μg of proteins was loaded onto SDS polyacrylamide gels (7.5%-15%) Following separation by SDS-PAGE, the proteins were transferred to nitrocellulose membranes (Amersham Pharmacia Biotech, Piscataway, NJ, USA). The membranes were blocked in blocking buffer (5% non-fat dried milk/1% Tween 20 in PBS) for 2 h at room temperature and then incubated with appropriate primary antibodies (1:1000) in blocking buffer overnight at 4°C. The blot was incubated with appropriate alkaline phosphatase (AP)-conjugated secondary antibodies. Immunoreactivity was detected by the addition of 5 mL AP buffer containing 16.5 mL BCIP and 33 mL of NBT at room temperature for 10 to 20 min. Blots were then photographed. β-Actin was used as a loading control.
Real-time PCR
RNA samples were reverse transcribed into cDNA using a DNA Synthesis kit (Trans Gen, Beijing, China). To determine the quantity of mRNA, the cDNA was amplified by real-time PCR with Top Green qPCR SuperMix (Trans Gen, Beijing, China) and GAPDH was used as the internal control. The SYBR Green assays were performed in duplicate or triplicate on an iCycler® thermal cycler (Bio-Rad, Hercules, USA). The relative expression levels were calculated using the 2−ΔΔCt method.
The following primers were used for amplification of ICOSL and the endogenous control (GAPDH): ICOSL forward 5'-GTGACTTACTACCTGCCTTAC-3', reverse 5'-CAGCCTGACCACCTCTT-3'; GAPDH forward 5'-GGTTGTCTCCTGCGACTTCA-3', reverse 5'-GGTGGTCCAGGGTTTCTTACT-3'.
Flow cytometry
BMMCs were washed twice with PBS and stained with FITC-labeled FcεRIα and PE-labeled CD117 for 30 min at room temperature. After washing, the samples were subjected to flow cytometric analysis (Cytomics FC500, Beckman Coulter). For analysis of T cell differentiation, cells were collected, washed with PBS twice, and stained with FITC-labeled anti-mouse CD4 monoclonal antibody (mAb) and PE-labeled antimouse CD25 mAb for 30 min at room temperature. Cells were subjected to fixation and permeabilization followed by staining with APC-labeled anti-mouse Foxp3 mAb for identification of regulatory T cells.
BMMC degranulation assay
After treating MCs with PBS and TNF-α at different concentrations for 24 h, BMMCs were pre-incubated with anti-DNP-IgE (100 ng/mL) for 24 h then challenged with DNP-HSA (200 ng/mL). After 1 h, conditioned media from these IgE/Ag-degranulated BMMCs were mixed into the culture system. After solubilization with 0.5% Triton X-100 in Tyrode's buffer, the enzymatic activities of β-hexosaminidase in supernatants and cell pellets were measured with p-nitrophenyl N-acetyl-b-D-glucosaminide in 0.1 M sodium citrate (pH 4.5) for 60 min at 37ºC. 
T cell-MC co-culture
BMMCs were stimulated with TNF-α (10 ng/mL, 20 ng/mL, 40 ng/mL, 80 ng/mL) for 24 h in complete RPMI 1640 medium. T cells (1×10 5 cells/well) were plated into 6-well flat-bottomed plates (Falcon; BD Biosciences) coated with 1 mg/mL anti-mouse CD3 mAb and then co-cultured with TNF-α stimulated or unstimulated BMMCs (1×10 5 cells/well) for 24 h.
Cytokine detection assays
Concentrations of IL-4, IL-10 and IFN-γ were measured in various cell co-culture supernatants by ELISA using cytokine specific kits according to the manufacturers' instructions. The optical density was measured at 450 nm using a microplate reader (BioTek, UK).
Statistical analysis
All experiments were repeated no less than three times and the results were presented as the mean of those independent experiments. All data were described as (mean±SD). SPSS 22.0 software was used for the statistical analysis. Comparisons between two independent groups were performed by Student's t-test. The Spearman test was used for correlation analyses. Statistical analysis was carried out using Prism 5.0 (GraphPad Software, San Diego, CA, USA) to evaluate the significance of differences between groups; *P < 0.05, **P < 0.01, ***P < 0.001.
Results
Characteristics of bone marrow mast cells and purification of CD4+T cell
To explore the effects of pre-treated MCs on CD4+ T cells, mast cells from bone marrow were generated in the presence of IL-3 and SCF following a 5-week culture. Fig. 1A -D illustrate the morphology of BMMCs, which contained an abundance of purple granules after toluidine blue staining. Identification of mast cells and by flow cytometric analysis of FcεRIα and CD117 suggested that the purity of mast cells exceeded 90% (Fig. 1E) . Similarly, flow cytometric analysis of the isolated CD4+ T cells revealed the purity of these sorted CD4+ T cell populations was more than 90%.
TNF-α upregulates ICOSL expression on MCs
To establish a model of high ICOSL expression by MCs, we first examined expression levels of ICOSL mRNA on MCs treated with PBS, TNF-α (50 g/mL), ox-LDL (50ng/mL), LPS (50 ng/mL) and ConA (50 ng/mL) for 24 h. Fig. 2A shows that only TNF-α upregulated ICOSL expression on MCs. We then stimulated MCs with different TNF-α concentrations (1 ng/ml, 5 ng/ml, 10 ng/mL 20 ng/mL, 40 ng/mL, and 80 ng/mL). RT-PCR (Fig. 2B ) and flow cytometry analysis (Fig. 2C, D) showed that TNF-α affected ICOSL level through a does-independent manner. The higher does of TNF-α may induce the change of other factors. These results showed that the expression levels of ICOSL increased in MCs due to the presence of lower does of TNF-α. Therefore, we chose 10ng/ml as TNF-α concentration in the next function experiments.
TNF-α inhibits MC degranulation through upregulation of ICOSL expression
To examine the effect of ICOSL on the degranulation of MCs, we measured MC degranulation after TNF-α treatment (Fig. 3 ). After stimulation with anti-DNP-IgE mAb and DNP-HSA, the β-hexosaminidase release represented the extent of degranulation. Pretreatment of MCs with TNF-α for 24 h led to a decrease in β-hexosaminidase release (Fig. 3  A, B ) and the reduction of the degranulation response does not depend on treatment toxicity (Fig. 3C) . Moreover, in ICOSL -/-MCs, pretreat with TNF-α did not affect MC degranulation (Fig. 3D) . These results demonstrated that TNF-α inhibited MC degranulation and stabilized MC membranes through upregulation of ICOSL expression. 
TNF-α upregulates ICOSL expression on MCs by activation of MAPK signaling pathway
To determine the signaling mechanisms involved in the effects of ICOSL on MCs, the expression of the phosphorylated and unphosphorylated forms of SAPK/JNK, ERK1/2, and p38 were investigated. As shown in Fig. 4A , there were notable differences in MAPK phosphorylation in the MCs after TNF-α treatment. The degree of phosphorylation of ERK1/2 was not as dramatic as that of p38 and SAPK/JNK. However, recovery after degranulation of TNF-α-treated MCs did not affect the MAPK signal or its phosphorylation level. As shown in Fig. 4B , a p38 MAPK inhibitor SB203580 [24] and a JNK MAPK inhibitor SP600125 [25] suppressed phosphorylation of p38 and JNK, respectively. These MAPK inhibitors also suppressed up-regulation of ICOSL by the TNF-α treatment (Fig. 4C, D) . This result suggested that TNF-α up-regulated ICOSL expression on MCs by activation of MAPK phosphorylation via a degranulation-independent mechanism. MC+T). CD4+ T cells were co-cultured with MCs with or without treatment at the ratio of 1:1 for 24 h in a 6-well plate pre-coated with anti-CD3 mAb (Fig. 5A) . Subsequently, the percentages of CD4+CD25+Foxp3+ T cells were determined by flow cytometry analysis. The MC+T group served as the control. Compared with the control, T cells in the stimulated group (TNF-α-MC+T group) showed a higher differentiation rate (Fig. 5B) . Meanwhile, the percentage of regulatory T cells decreased in the deTNF-α-MC+T group. In ICOSL -/-MCs co-cultured with T cells, TNF-α-treatment or degranulation-recovery did affect the differentiation of regulatory T cells (Fig.  5C ). According to these findings, TNF-α-treated MCs promote CD4 + T cell differentiation to CD4+CD25+Foxp3+ T cells through up-regulation of ICOSL expression, while degranulation inhibited the ability of TNF-α to induce the differentiation of regulatory T cells. 
TNF-α-treated MCs promote the differentiation of regulatory T cells We investigated the effects of ICOSL on the differentiation of T cells in six experimental groups: (1) MCs co-cultured with T cells (MC+T); (2) MC degranulation (stimulation with anti-DNP-IgE mAb and DNP-HSA) and then co-cultured with T cells (deMC+T); (3) TNF-α-treated MCs and then co-cultured with T cells (TNF-α-MC+T); (4) degranulation-recovered TNF-α-treated
TNF-α treated MCs induce a shift in cytokine expression from a Th1 to a Th2 profile
Based on the finding that MCs influence T cell differentiation, we also analyzed the concentrations of Th1-type (IFN-γ) and Th2-type (IL-4 and IL-10) cytokines in the co-culture. Compared with the MC+T group, IFN-γ secretion and mRNA expression levels of IFN-γ and VEGF were decreased in the TNF-α-MC+T group, while the secretion of IL-4 and IL-10 and mRNA expression level of IL-10 were increased (Fig. 6A,B) . Interestingly, when compared with TNF-α-MC+T group, IL-4 and IL-10 were significantly decreased in the deTNF-α-MC+T group, while there was no significant difference in IFN-γ secretion. IL-4, IL-10 and IFN-γ were significantly decreased via TNF-α concentration-dependence in the deTNF-α-MC+T group (Fig. 6C) . In ICOSL -/-MCs co-cultured with T cells, TNF-α-treatment or degranulationrecovery did affect the shift in cytokine expression from a Th1 to a Th2 profile (Fig. 6D) . These results indicate that TNF-α-treated MCs influence the Th1/Th2 distribution by upregulation of ICOSL expression and inhibition of MC degranulation.
Discussion
Recently, BMMCs have become a focus of research due to their ubiquitous distribution in the connective and vascularized tissues or cavities throughout the body and their critical roles in the regulation in variety of immune processes and many inflammatory diseases [2, 26, 27] . Currently, mast cells are considered to function in a manner that is similar to antigen presenting cells in host defense and homeostasis via the release of cytokines and other mediators that recruit T cells to sites of infection [27, 28] . According to previous studies, the interaction of ICOS with its sole ligand, ICOSL (also known as B7-related protein-1) triggers key T cell activities, including cytokine production and differentiation into the T follicular helper (Tfh) cell lineage over effector lineages [29] [30] [31] [32] . Therefore, mast cells may play other important roles in homeostasis and allergic inflammation. It is well-known that TNF-α plays a 
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Cellular Physiology and Biochemistry key role in these conditions; however, the ability of TNF-α to influence MC functions in T cells differentiation remains to be elucidated [33] . In this study, we showed that TNF-α stimulation upregulated ICOSL expression on MCs and inhibited degranulation, while several other exogenous stimulators such as ox-LDL, LPS and ConA did not (Fig. 2-3 ). Co-culture of MCs and CD4 + T cells revealed that TNF-α stimulation enhances the immunoregulatory functions of MCs, with corresponding changes in the percentage of regulatory T cells. Specifically, TNF-α treated MCs promoted CD4+ T cell differentiation to CD4+CD25+Foxp3+ T cells, while this effect was inhibited by MC degranulation (Fig. 5) . Furthermore, we identified changes in the secretion of Th1/Th2 type cytokines in the supernatants collected from the co-culture system. Fig. 6 shows that the levels of the Th1 marker cytokine, IFN-γ, decreased significantly, while expression of the Th2 marker cytokines, IL-4 and IL-10, increased. However, in the presence of degranulated MCs, the levels of IL-4 and IL-10 decreased compared with that in the presence of undegranulated DCs, while there was no significant difference in the levels of IFN-γ. We also found that, in the MC-T co-culture system with TNF-α-untreated MCs, the levels of IFN-γ, IL-4 and IL-10 increased in the presence of degranulated MCs, compared with the levels detected in the presence of undegranulated MCs. Based on these findings, we conclude that MCs promote the differentiation and functions of regulatory T cells by upregulating the expression of ICOSL. MCs regulate T cell cytokines secretion through degranulation commonly; however, in the present study, we revealed that stimulation of MCexpressed molecules such as ICOSL may participate in the regulation of these processes via cell-cell interactions. This novel role for MC-derived ICOSL in the regulation of the immune microenvironment has important implications for the design of therapeutic strategies. The mechanism underlying the inducible expression of ICOSL is not clear. A recent study demonstrated increased ICOSL expression during the maturation of plasmacytoid DCs [34] , MC+T. Each group are presented as the mean ± SD of at least three independent experiments. Significant differences: *P<0.05; **P<0.01; ***P<0.001. Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry although the exact mechanism was unknown. Here, we found that inducible expression of ICOSL on MCs was TNF-α-dependent for a short period. We suspected that cumulative effects leading to the functional modification of MCs occurred during the stimulation. Fig. 4A shows that the ICOSL expression is related to MAPK and p-MAPK signals; thus, we conclude that TNF-α upregulates ICOSL by activation of the MAPK signaling pathway. Furthermore, degranulation of MCs has no influence on MAPK expression and its phosphorylation status, which may correlate with other signaling pathways. Unfortunately, a direct connection between MAPK signaling activation and ICOSL expression could not be investigated due to the restrictions of time and conditions. Further studies are required to confirm TNF receptor expression on MCs for clarification of the mechanism underlying TNF-α-mediated stimulation of MCs as well as the potential expression of other mediators that could connect MAPK/p-MAPK activation and ICOSL induction in the TNF-α culture system and play key roles in this process.
Conclusion
In summary, although the exact mechanism of TNF-α dependent ICOSL expression on MCs was not fully elucidated, we demonstrate novel regulatory roles of MCs in the differentiation of CD4+ T cells to regulatory T cells via the ICOSL/ICOS interaction. These findings provide insights into the molecules and signaling pathways involved in the interaction of MCs with other immune cells, which it is hoped will lead to the development of different therapeutic strategies aimed at boosting or suppressing specific MC functions, depending on the pathological context.
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